SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-178607
Filing Date
2024-07-12
Accepted
2024-07-12 16:31:03
Documents
14
Period of Report
2024-07-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d853366d8k.htm   iXBRL 8-K 28229
  Complete submission text file 0001193125-24-178607.txt   190437

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snse-20240710.xsd EX-101.SCH 3872
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20240710_def.xml EX-101.DEF 14097
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20240710_lab.xml EX-101.LAB 23426
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20240710_pre.xml EX-101.PRE 15130
17 EXTRACTED XBRL INSTANCE DOCUMENT d853366d8k_htm.xml XML 5603
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 241114889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)